Tesetaxel as First-line Therapy for Metastatic Breast Cancer

NCT01221870 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Tesetaxel once every 3 weeks
DRUG: Tesetaxel once weekly

Sponsor

Genta Incorporated